Latest filing published 06 Dec 2023 for Maxcyte, INC., €919. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Douglas Doerfler on record concern Maxcyte, Inc., in the capacity of chief executive. The record holds 11 filings, for trades running from 12 November 2021 to 4 December 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 6 December 2023, the filings show an option exercise worth €919 in Maxcyte, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations